Cite
HARVARD Citation
Pires da Silva, I. et al. (2020). Site‐specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti–PD‐1 therapy. Cancer. 126 (1), pp. 86-97. [Online].